AC Immune SA (FRA:IMR)
Germany flag Germany · Delayed Price · Currency is EUR
2.890
+0.015 (0.52%)
Last updated: Jan 28, 2026, 8:12 AM CET

AC Immune Income Statement

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
4.3727.3114.83.94-15.43
Revenue Growth (YoY)
-89.33%84.51%276.14%---86.03%
Cost of Revenue
61.662.5754.6160.3462.2859.49
Gross Profit
-57.23-35.26-39.81-56.4-62.28-44.06
Selling, General & Admin
15.8817.2615.3115.7917.9118.56
Other Operating Expenses
-0.04-0.14-1.49-1.34-1.18-1.35
Operating Expenses
15.8517.1213.8214.4516.7317.2
Operating Income
-73.08-52.38-53.62-70.85-79.01-61.26
Interest Expense
-0.18-0.13-0.18-0.36-0.58-0.18
Interest & Investment Income
2.43.21.040.076.490.08
Currency Exchange Gain (Loss)
-0.55-1.6-1.470.390.11-0.56
EBT Excluding Unusual Items
-71.4-50.91-54.22-70.74-72.99-61.92
Pretax Income
-71.87-50.91-54.22-70.74-72.99-61.92
Income Tax Expense
000.010.010-
Net Income
-71.87-50.92-54.23-70.75-73-61.92
Net Income to Common
-71.87-50.92-54.23-70.75-73-61.92
Shares Outstanding (Basic)
10010085847572
Shares Outstanding (Diluted)
10010085847572
Shares Change (YoY)
4.26%17.71%1.36%11.48%4.24%1.12%
EPS (Basic)
-0.72-0.51-0.64-0.85-0.97-0.86
EPS (Diluted)
-0.72-0.51-0.64-0.85-0.97-0.86
Free Cash Flow
-47.765.27-61.21-74.81-68.32-61.22
Free Cash Flow Per Share
-0.470.66-0.72-0.90-0.91-0.85
Gross Margin
--129.12%-268.94%---285.50%
Operating Margin
-1671.43%-191.80%-362.30%-1800.43%--396.99%
Profit Margin
-1643.89%-186.44%-366.41%-1798.04%--401.28%
Free Cash Flow Margin
-1091.10%238.99%-413.55%-1901.07%--396.75%
EBITDA
-71.65-50.89-51.95-69.05-77.11-59.73
EBITDA Margin
--186.36%----
D&A For EBITDA
1.421.491.671.791.91.54
EBIT
-73.08-52.38-53.62-70.85-79.01-61.26
EBIT Margin
--191.80%----
Revenue as Reported
4.3727.3114.83.94-15.43
Source: S&P Global Market Intelligence. Standard template. Financial Sources.